Furthermore, the presence of this polymorphism in arthritis and patients resistant to antituberculosis drugs generates an increase in serum levels of IL‐17A [79, 80, 81], as observed by Correa in serum and gingival tissue [59]. Here, IL17A is linked to arthritic joint disease.